Industry news

Russian pharmaceutical market developing

Jim Butschli, Healthcare Packaging

Investments from its government and the international community continue; meanwhile, unhealthy lifestyles contribute to greater need for medications.

Russia has the right prescription for pharma companies

Ruud Dobber, Financial Times / Beyondbrics

The country still has enormous potential and is one of the few growing markets in what is a predominantly barren global economy. There is good cause for foreign businesses in Russia to be optimistic, not least in pharmaceuticals.

Sberbank Eyes $800M Medical Investment

Irina Filatova, The Moscow Times

Sberbank might invest up to $800 million to build a medical center in Moscow as part of a $1.5 billion hub presented Wednesday to upgrade the country's health care sector.

Biotechnopark establishes its research center in Koltsovo

Venture Business News

Biotechnopark, which is currently under construction in Koltsovo near Novosibirsk, will establish a research center for collective use of upscale laboratory equipment for bacterial and viral researches. The question of further development of the Biotechnopark infrastructure was considered at a meeting of the regional government.

Prescribing the right rules for Pharma

Gaurav Shah, Business Line

For efficient and ethical growth of the clinical trials industry, there is need for a strong centralised regulatory regime to enforce guidelines.

Online Medical Startup Attracts $2M in Investment

Alexander Winning, The Moscow Times

A Russian venture-capital fund and an American investor have agreed to invest $2 million in VitaPortal, an online medical startup aiming to improve Russians' access to information on doctors, medicine and healthy living.

India, Russia to ease access to pharmaceutical markets

Sergey Ivanov, Combined Report, Russia and India Reports

New regulation in both countries will cut down registration procedures that can take up to 3 years, opening up new avenues.

Russian government to stimulate conduct of clinical trials by foreign pharma producers

The Pharma Letter

The Russian government plans to actively attract the world's largest pharmaceutical manufacturers to the country, through the creation of conditions to carry out clinical trials of their drugs in the country and providing their access to Russian patients, according to local media reports.

Takeda Pharma considering expansion in Russia and other BRIC countries

The Pharma Letter

Amid the falling dynamics in the European Union and the USA, Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) is considering a big expansion into the Russian pharmaceutical market, along with other BRIC (Brazil, Russia, India and China) markets, in the coming years.

Russia Establishes Clinical Trial Hub

Alex Philippidis, Insight & Intelligence

Cost and speed play big roles in the country’s increased presence in the market.